日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England

英格兰接受恩扎卢胺或阿比特龙治疗的转移性去势抵抗性癌症患者的特征和医疗资源利用情况

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP-24-01045
Bahl, Amit; Faria, Rita; Merseburger, Axel S; Attard, Gert; Snijder, Robert; Sodatonou, Hanna; Stark, Sari; Pranzo, Alessandra; Martins, Karla; Rozario, Nigel; Ridsdale-Smith, Jess; Chilelli, Andrew
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Diagnostic Performance and Clinical Utility of the Uromonitor(®) Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-Analysis

Uromonitor® 分子尿液检测在膀胱尿路上皮癌诊断中的诊断性能和临床应用价值：系统评价和诊断准确性荟萃分析

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics16020285
Rodas Garzaro, Julio Ruben; Kravchuk, Anton; Burger, Maximilian; Wolff, Ingmar; Lebentrau, Steffen; Rubio-Briones, José; Brás, João Paulo; Gilfrich, Christian; Siepmann, Stephan; Pahernik, Sascha; Merseburger, Axel S; Heidenreich, Axel; May, Matthias
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation

利用 ChatGPT-4 进行前列腺癌研究的通俗易懂的摘要生成，以促进以患者为中心的沟通：大规模生成式人工智能性能评估

期刊:Journal of Medical Internet Research
影响因子:6
doi:10.2196/76598
Rinderknecht, Emily; Engelmann, Simon U; Saberi, Veronika; Kirschner, Clemens; Kravchuk, Anton P; Schmelzer, Anna; Breyer, Johannes; Goßler, Christopher; Mayr, Roman; Gilfrich, Christian; Burger, Maximilian; von Winning, Dominik; Borgmann, Hendrik; Wülfing, Christian; Merseburger, Axel S; Haas, Maximilian; May, Matthias
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer

阿帕鲁胺治疗后前列腺特异性抗原最低值超低：同步性与异时性转移性激素敏感性前列腺癌的疗效

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2025.05.001
Wenzel, Mike; Steuber, Thomas; Siech, Carolin; Kriegmair, Maximilian; Hoeh, Benedikt; Tilki, Derya; Merseburger, Axel S; Chun, Felix K H; Mandel, Philipp
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial

一项国际多中心随机对照试验，比较膀胱肿瘤整块切除术与传统经尿道膀胱肿瘤切除术：膀胱尿路上皮癌整块切除术（EBRUC）II期试验的初步结果

期刊:Bju International
影响因子:4.4
doi:10.1111/bju.16543
Struck, Julian Peter; Moharam, Nadim; Leitenberger, Armin; Weber, Jörg; Lusuardi, Lukas; Oswald, David; Rassweiler, Jens J; Fiedler, Marcel; Horňák, Jakub; Babjuk, Marek; Micali, Salvatore; Zaraca, Carlo; Spreu, Thomas; Friedersdorff, Frank; Borgmann, Hendrik; Merseburger, Axel S; Kramer, Mario W
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey

指导晚期尿路上皮癌一线治疗决策：一项全球调查

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf333
Grande, Enrique; Bellmunt, Joaquim; Hussain, Syed A; Al Mansour, Mubarak M; Bamias, Aristotle; Barthélémy, Philippe; Benjamin, David J; Blais, Normand; Bourlon, Maria T; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Félix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C; Matsubara, Nobuaki; Merseburger, Axel S; Mukherji, Deborah; Park, Chandler H; Tran, Ben; da Trindade, Karine Martins; Ürün, Yüksel; Kamat, Ashish M; Birtle, Alison J
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study

德国一项AVENGER研究比较了阿比特龙与恩扎卢胺在未经化疗的转移性去势抵抗性前列腺癌患者中的心血管风险和生存率。

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03132-8
Merseburger, Axel S; Dornstauder, Eugen; Ohlmann, Carsten-Henning; Aprikian, Armen; Junker, Sophia; Hahn, Philipp; Chilelli, Andrew; Stoelzel, Matthias; Serikoff, Alexis; Spitzer, Stefan G
肿瘤
肿瘤免疫
ENG
前列腺癌
AVEN
发表日期：2025
文献求助 收藏

Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study

在转移性去势抵抗性前列腺癌患者中，与恩扎卢胺相比，醋酸阿比特龙与主要心血管事件的关联性：EVADE 研究的事后分析

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-025-05841-9
Bahl, Amit; Chilelli, Andrew; Faria, Rita; Rozario, Nigel; Snijder, Robert; Stark, Sari; Merseburger, Axel S
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9

回复 Parth Aphale、Shashank Dokania 和 Himanshu Shekhar 致编辑的信，内容关于 Bahl A、Chilelli A、Faria R 等人发表的题为“转移性去势抵抗性前列腺癌患者中，醋酸阿比特龙与恩扎卢胺相比，主要心血管事件的关联性：EVADE 研究的事后分析”的文章。该文章发表于《世界泌尿外科杂志》43:465。https://doi.org/10.1007/s00345-025-05841-9

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-025-06100-7
Bahl, Amit; Chilelli, Andrew; Faria, Rita; Rozario, Nigel; Snijder, Robert; Stark, Sari; Merseburger, Axel S
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Proteomic analysis of the urothelial cancer landscape

尿路上皮癌概况的蛋白质组学分析

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-48096-5
Franz F Dressler, Falk Diedrichs, Deema Sabtan, Sofie Hinrichs, Christoph Krisp, Timo Gemoll, Martin Hennig, Paulina Mackedanz, Mareile Schlotfeldt, Hannah Voß, Anne Offermann, Jutta Kirfel, Marie C Roesch, Julian P Struck, Mario W Kramer, Axel S Merseburger, Christian Gratzke, Dominik S Schoeb, Ark
肿瘤
发表日期：2024
文献求助 收藏